STERIS (STE) Revenue — Quarter Ended Jun 30, 2025
Revenue decreased from the prior quarter but increased compared to the same period last year. The sequential decline followed a period of growth in the preceding quarter.
Key takeaway
Quarter ended Jun 30, 2025 · FY2026 Q1
Revenue decreased from the prior quarter but increased compared to the same period last year. The sequential decline followed a period of growth in the preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.4B
Revenue reported for this quarter.
Quarter-over-quarter
-6.0%
Change from the immediately preceding quarter.
Year-over-year
+8.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $1.3B | +7.3% |
| Dec 31, 2024 | $1.4B | +5.6% |
| Mar 31, 2025 | $1.5B | +4.3% |
| Jun 30, 2025 | $1.4B | +8.7% |
Revenue performance
Revenue declined sequentially, reversing the growth trend seen in the previous quarter.
Quarterly comparison
Compared to the immediately preceding quarter, revenue was lower. Compared to the same quarter one year earlier, revenue was higher.
What to watch
Operating cash flow rose, driven by higher earnings and favorable working capital timing.